Guillaume Cadiot

Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors

Martyn Caplin, Marianne Pavel, Jarosław B. Ćwikła et al. · New England Journal of Medicine · 2014 · 1.9K citations · Full text

Medicine, Endocrinology, Oncology +17

Daily Oral Everolimus Activity in Patients With Metastatic Pancreatic Neuroendocrine Tumors After Failure of Cytotoxic Chemotherapy: A Phase II Trial

James C. Yao, Catherine Lombard‐Bohas, Éric Baudin et al. · Journal of Clinical Oncology · 2009 · 649 citations · Full text

Medicine, Oncology, Pharmacology +17

ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms: Functional Pancreatic Endocrine Tumor Syndromes

Robert T. Jensen, Guillaume Cadiot, Maria Luisa Brandi et al. · Neuroendocrinology · 2012 · 613 citations · Full text

Medicine, Endocrinology, Oncology +13

Ineffectiveness of <i>Lactobacillus johnsonii</i> LA1 for prophylaxis of postoperative recurrence in Crohn’s disease: a randomised, double blind, placebo controlled GETAID trial

Philippe Marteau, Marc Lémann, Philippe Seksik et al. · Gut · 2005 · 411 citations · Full text

Life Sciences, Immunology, Surgery +16

Infliximab Plus Azathioprine for Steroid-Dependent Crohn’s Disease Patients: A Randomized Placebo-Controlled Trial

Marc Lémann, Jean–Yves Mary, Bernard Duclos et al. · Gastroenterology · 2006 · 372 citations

Pharmacy, Immunology, Pharmacotherapy +12